Lembas Bio Ltd.
Biomed — Stage: R&D. Est: 2024. Tags: Artificial Intelligence, FoodTech, Life Sciences. Lembas is an AI-powered bioactive discovery company, pioneering the next generation of science-backed ingredients for functional foods and supplements. Its first solution GLP-1 Edge™, is a natural peptide that supports appetite regulation and metabolic health by enhancing the body’s own GLP-1 response. At the core of Lembas is a proprietary AI platform that accelerates the discovery and design of targeted bioactive peptides. GLP-1 Edge™ is food-grade, clinically validated and easy to integrate into everyday products, like bars, shakes, snacks, gummies and supplements. It works with the body, making it an ideal companion for consumers looking to manage their weight naturally, safely and sustainably.. Web: https://www.hellolembas.com